Baker McKenzie represented Takeda in its global strategic collaboration with Innovent Biologics, bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors. Under terms of the
Baker McKenzie represented Takeda in its global strategic collaboration with Innovent Biologics, bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors. Under terms of the
Rayonier (NYSE: RYN) and PotlatchDeltic (Nasdaq: PCH) announced they have entered into a definitive agreement to combine in an all-stock merger of equals, creating a leading domestic land resources owner
Linklaters has advised Vonovia SE on its successful debut in the Australian bond market. The issuance volume of the unsecured bonds amounts to 850 million Australian dollars (approximately EUR 475
Clifford Chance have advised Zelestra in signing an innovative long-term tolling agreement with BKW enabling the delivery of a major 2 GWh battery storage project in Italy. This is the first
Baker McKenzie has advised international IT service provider Fellowmind on its acquisition of Xperity, expert in Microsoft Dynamics 365 CRM. The joining of forces is part of Fellowmind’s international growth
Sidley represented the joint placing agents CLSA Limited and Haitong International Securities Company Limited in the placing of 20.7 million new H shares under general mandate by InnoScience (Suzhou) Technology
London—Dentons, the world’s largest global law firm, has advised CPI Property Group (CPIPG) on the issuance of £300 million 8.875% Fixed Rate Resettable Undated Type A Subordinated Notes (the Notes)
Baker McKenzie represented Takeda in its global strategic partnership with Innovent Biologics, bolstering Takeda’s oncology pipeline with next-generation investigational medicines for the treatment of solid tumors. Under terms of the
Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing and commercializing innovative
Global law firm Clifford Chance is advising leading global investment firm KKR on the proposed investment by funds managed by KKR in Peak Reinsurance Holdings Limited, the group holding company